Camurus (CAMX) announces expansion of Lilly collaboration, decision extends Lilly's exclusive, global rights to Camurus' FluidCrystal technology Jun 1, 2026 11:35AM
FDA accepts Camurus resubmission for acromegaly treatment Oclaiz Jan 9, 2026 09:38AM
Camurus (CAMX) Announces CHMP recommends approval of Oczyesa for treatment of acromegaly in the EU Apr 25, 2025 10:17AM